Leukemia-specific cells are specifically triggered immune cells that produce interferon gamma (IFNg), tumor necrosis factor α (TNFα) or initiate cells’ degranulation in the presence of leukemia-associated antigens (LAA) like WT1 or PRAME [25,42]. This evidence concerns the gene IFNG and leukemia.